Drug Pipeline

Phesgo Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
5
Active Studies
2
Recruiting
2
Phase 3
3
Top Sponsors
Active Studies by Phase
Phase 3
2
Phase 2
2
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT05894239 A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo… Metastatic Breast Cancer Recruiting
NCT05296798 A Study to Evaluate the Efficacy and Safety of Giredestrant in Combination With Phesgo… Locally Advanced or Metastatic Breast Cancer Active, Not Recruiting
Phase 2
NCT06068985 Classifying for HER2 Dependence to De-Escalate Neoadjuvant Chemotherapy in Patients With… Breast Cancer Active, Not Recruiting
NCT06172127 PHESGO Maintenance After T-DXd Short Induction for HER2+ Unresectable Locally Recurrent… HER2-positive Breast Cancer Active, Not Recruiting
Phase 1/2
NCT04802759 A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in… Inoperable, Locally Advanced or Metastatic, ER-positive Breast Cancer Recruiting
Sponsors Running Phesgo Trials
Disease Areas
Get alerts when Phesgo trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free